These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 24862193)
21. Selection and characterization of naturally occurring single-domain (IgNAR) antibody fragments from immunized sharks by phage display. Dooley H; Flajnik MF; Porter AJ Mol Immunol; 2003 Sep; 40(1):25-33. PubMed ID: 12909128 [TBL] [Abstract][Full Text] [Related]
22. Isolation and characterization of malaria PfHRP2 specific V Leow CH; Fischer K; Leow CY; Braet K; Cheng Q; McCarthy J Malar J; 2018 Oct; 17(1):383. PubMed ID: 30355309 [TBL] [Abstract][Full Text] [Related]
23. Antigen specific VNAR screening in whitespotted bamboo shark (Chiloscyllium plagiosum) with next generation sequencing. Zhong B; Sun S; Luo Z; Yang J; Jia L; Zheng K; Tang W; Jiang X; Lyu Z; Chen J; Chen G Fish Shellfish Immunol; 2024 Jul; 150():109661. PubMed ID: 38821227 [TBL] [Abstract][Full Text] [Related]
24. Humanization of the Shark V Zhang YF; Sun Y; Hong J; Ho M Curr Protoc; 2023 Jan; 3(1):e630. PubMed ID: 36594750 [TBL] [Abstract][Full Text] [Related]
25. Isolation of the new antigen receptor from wobbegong sharks, and use as a scaffold for the display of protein loop libraries. Nuttall SD; Krishnan UV; Hattarki M; De Gori R; Irving RA; Hudson PJ Mol Immunol; 2001 Aug; 38(4):313-26. PubMed ID: 11566324 [TBL] [Abstract][Full Text] [Related]
26. [Progress in shark single-domain antibody]. Liu X; Chen Q Sheng Wu Gong Cheng Xue Bao; 2020 Jun; 36(6):1069-1082. PubMed ID: 32597058 [TBL] [Abstract][Full Text] [Related]
27. Shark New Antigen Receptor (IgNAR): Structure, Characteristics and Potential Biomedical Applications. Juma SN; Gong X; Hu S; Lv Z; Shao J; Liu L; Chen G Cells; 2021 May; 10(5):. PubMed ID: 34066890 [TBL] [Abstract][Full Text] [Related]
28. Rapid isolation of IgNAR variable single-domain antibody fragments from a shark synthetic library. Shao CY; Secombes CJ; Porter AJ Mol Immunol; 2007 Jan; 44(4):656-65. PubMed ID: 16500706 [TBL] [Abstract][Full Text] [Related]
29. In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties. Steven J; Ubah OC; Buschhaus M; Kovaleva M; Ferguson L; Porter AJ; Barelle CJ Methods Mol Biol; 2020; 2070():115-142. PubMed ID: 31625093 [TBL] [Abstract][Full Text] [Related]
30. Construction and next-generation sequencing analysis of a large phage-displayed V Feng M; Bian H; Wu X; Fu T; Fu Y; Hong J; Fleming BD; Flajnik MF; Ho M Antib Ther; 2019 Jan; 2(1):1-11. PubMed ID: 30627698 [No Abstract] [Full Text] [Related]
32. Isolation of anti-toxin single domain antibodies from a semi-synthetic spiny dogfish shark display library. Liu JL; Anderson GP; Goldman ER BMC Biotechnol; 2007 Nov; 7():78. PubMed ID: 18021450 [TBL] [Abstract][Full Text] [Related]
33. IgNAR characterization and gene loci identification in whitespotted bamboo shark (Chiloscyllium plagiosum) genome. Jia L; Wang Y; Shen Y; Zhong B; Luo Z; Yang J; Chen G; Jiang X; Chen J; Lyu Z Fish Shellfish Immunol; 2023 Feb; 133():108535. PubMed ID: 36649810 [TBL] [Abstract][Full Text] [Related]
34. Human TNF cytokine neutralization with a vNAR from Heterodontus francisci shark: a potential therapeutic use. Camacho-Villegas T; Mata-Gonzalez T; Paniagua-Solis J; Sanchez E; Licea A MAbs; 2013; 5(1):80-5. PubMed ID: 23221782 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody. Cheong WS; Leow CY; Abdul Majeed AB; Leow CH Int J Biol Macromol; 2020 Mar; 147():369-375. PubMed ID: 31926922 [TBL] [Abstract][Full Text] [Related]
36. Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1. Stocki P; Szary J; Rasmussen CLM; Demydchuk M; Northall L; Logan DB; Gauhar A; Thei L; Moos T; Walsh FS; Rutkowski JL FASEB J; 2021 Feb; 35(2):e21172. PubMed ID: 33241587 [TBL] [Abstract][Full Text] [Related]
37. Shark variable new antigen receptor biologics - a novel technology platform for therapeutic drug development. Kovaleva M; Ferguson L; Steven J; Porter A; Barelle C Expert Opin Biol Ther; 2014 Oct; 14(10):1527-39. PubMed ID: 25090369 [TBL] [Abstract][Full Text] [Related]
38. Next-generation flexible formats of VNAR domains expand the drug platform's utility and developability. Ubah OC; Buschhaus MJ; Ferguson L; Kovaleva M; Steven J; Porter AJ; Barelle CJ Biochem Soc Trans; 2018 Dec; 46(6):1559-1565. PubMed ID: 30381336 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis. Kovaleva M; Johnson K; Steven J; Barelle CJ; Porter A Front Immunol; 2017; 8():1121. PubMed ID: 28993766 [TBL] [Abstract][Full Text] [Related]
40. Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies. Lipovsek D; Lippow SM; Hackel BJ; Gregson MW; Cheng P; Kapila A; Wittrup KD J Mol Biol; 2007 May; 368(4):1024-41. PubMed ID: 17382960 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]